$10.37
-0.01[-0.10%]
Last update: 8:02AM Get Real Time Here
Cellebrite DI
(NASDAQ:CLBT)Cellebrite DI Stock (NASDAQ:CLBT), Analyst Ratings, Price Targets, Predictions
Cellebrite DI Ltd has a consensus price target of $11.06, established from looking at the 28 latest analyst ratings. The last 3 analyst ratings were released from Craig-Hallum, B of A Securities, and Needham on April 1, 2024, April 1, 2024, and March 28, 2024. With an average price target of $14.17 between Craig-Hallum, B of A Securities, and Needham, there's an implied 36.61% upside for Cellebrite DI Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
B of A Securities
Needham
William Blair
B of A Securities
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cellebrite DI
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/01/2024 | CLBT | Buy Now | Cellebrite DI | $10.37 | 54.29% | Craig-Hallum | Jeff Van Rhee | $14 → $16 | Maintains | Buy | Get Alert |
| 04/01/2024 | CLBT | Buy Now | Cellebrite DI | $10.37 | 25.36% | B of A Securities | Tal Liani | $12 → $13 | Maintains | Buy | Get Alert |
| 03/28/2024 | CLBT | Buy Now | Cellebrite DI | $10.37 | 30.18% | Needham | Mike Cikos | $13 → $13.5 | Maintains | Buy | Get Alert |
| 03/13/2024 | CLBT | Buy Now | Cellebrite DI | $10.37 | — | William Blair | Jonathan Ho | — | Upgrade | Market Perform → Outperform | Get Alert |
| 02/16/2024 | CLBT | Buy Now | Cellebrite DI | $10.37 | 15.72% | B of A Securities | Tomer Zilberman | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 02/15/2024 | CLBT | Buy Now | Cellebrite DI | $10.37 | 25.36% | Needham | Mike Cikos | $10 → $13 | Maintains | Buy | Get Alert |
| 08/30/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -3.57% | Needham | Mike Cikos | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -3.57% | JP Morgan | Sterling Auty | $8 → $10 | Maintains | Overweight | Get Alert |
| 08/09/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -3.57% | Needham | Mike Cikos | $7 → $10 | Maintains | Buy | Get Alert |
| 07/19/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | 6.08% | Craig-Hallum | Jeff Van Rhee | → $11 | Initiates | → Buy | Get Alert |
| 05/17/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -32.5% | Needham | Mike Cikos | → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -32.5% | Needham | Mike Cikos | → $7 | Reiterates | → Buy | Get Alert |
| 03/14/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -32.5% | Needham | Mike Cikos | $6.5 → $7 | Maintains | Buy | Get Alert |
| 02/16/2023 | CLBT | Buy Now | Cellebrite DI | $10.37 | -37.32% | Needham | Mike Cikos | → $6.5 | Reiterates | → Buy | Get Alert |
| 08/12/2022 | CLBT | Buy Now | Cellebrite DI | $10.37 | -42.14% | B of A Securities | Tal Liani | $6.5 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 08/12/2022 | CLBT | Buy Now | Cellebrite DI | $10.37 | -3.57% | Cowen & Co. | Shaul Eyal | $13 → $10 | Maintains | Outperform | Get Alert |
| 08/12/2022 | CLBT | Buy Now | Cellebrite DI | $10.37 | — | William Blair | Jonathan Ho | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/11/2022 | CLBT | Buy Now | Cellebrite DI | $10.37 | -37.32% | Needham | Mike Cikos | $6 → $6.5 | Maintains | Buy | Get Alert |
| 05/13/2022 | CLBT | Buy Now | Cellebrite DI | $10.37 | -3.57% | Deutsche Bank | Jamie Shelton | $11 → $10 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cellebrite DI (CLBT)?
The latest price target for Cellebrite DI (NASDAQ: CLBT) was reported by Craig-Hallum on April 1, 2024. The analyst firm set a price target for $16.00 expecting CLBT to rise to within 12 months (a possible 54.29% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cellebrite DI (CLBT)?
The latest analyst rating for Cellebrite DI (NASDAQ: CLBT) was provided by Craig-Hallum, and Cellebrite DI maintained their buy rating.
When was the last upgrade for Cellebrite DI (CLBT)?
The last upgrade for Cellebrite DI Ltd happened on March 13, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Cellebrite DI Ltd.
When was the last downgrade for Cellebrite DI (CLBT)?
The last downgrade for Cellebrite DI Ltd happened on August 12, 2022 when B of A Securities changed their price target from $6.5 to $6 for Cellebrite DI Ltd.
When is the next analyst rating going to be posted or updated for Cellebrite DI (CLBT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellebrite DI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellebrite DI was filed on April 1, 2024 so you should expect the next rating to be made available sometime around April 1, 2025.
Is the Analyst Rating Cellebrite DI (CLBT) correct?
While ratings are subjective and will change, the latest Cellebrite DI (CLBT) rating was a maintained with a price target of $14.00 to $16.00. The current price Cellebrite DI (CLBT) is trading at is $10.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.